Ms. Julia Becker reports

TEMPRAMED ANNOUNCES CONTINUANCE INTO ONTARIO

Tempramed Technologies Ltd. has continued out of the provincial jurisdiction of British Columbia under the Business Corporations Act (British Columbia) into the provincial jurisdiction of Ontario under the Business Corporations Act (Ontario). Shareholders approved the continuance into the OBCA by special resolution at the company's special meeting of shareholders held on April 10, 2026.

In connection with the continuance, the company has replaced its notice of articles and articles with new articles of continuance and bylaws, respectively, under the OBCA, which can be accessed at the company's profile at SEDAR+. The Cusip/ISIN for the company's common shares and the stock symbol for the company's common shares remain unchanged.

About Tempramed Technologies Ltd.

Tempramed is a global medical device company with a portfolio of innovative, temperature-controlled medication storage solutions. Founded with the mission to safeguard the effectiveness of life-saving medications, Tempramed develops patented, Food and Drug Administration-registered, thermal insulation devices that work 24-seven without batteries or external power. With a product line already in market including Vivi Cap, Vivi Cap Smart, Vivi Epi and Vivi Med, Tempramed enables patients and health care providers to confidently manage temperature-sensitive medications anywhere, any time. With operations in North America, Europe and Asia, Tempramed will continue to expand globally, offering a solution for medication protection and adherence.